Presseaussendungen zu "Magnitude"

85 Aussendungen

Die ORF-"Millionenshow": Mit Udo Jürgens zu 300.000 Euro

ACHTUNG, SPERRFRIST FÜR ALLE MEDIEN (FERNSEHEN, RADIO, INTERNET, TELETEXT UND PRINT) BIS HEUTE, MONTAG, 11. FEBRUAR, 21.00 UHR BEACHTEN

ORF
OTS0075
11.02.2013 11:37

Spannung pur bei der ORF-"Millionenshow": Am 11. Februar stellt Armin Assinger die Millionenfrage

Gibt es bei der "Millionenshow" ein Feuerwerk und Konfettiregen?

ORF
OTS0008
08.02.2013 08:18

Routes Europe 2012 Wins Conference of the Year

Erik Sakkov and the team from Tallinn Airport collect prestigious award from the Estonian Convention Bureau

OTE0008
24.01.2013 13:41

Bill Gates Accepts Hunger Award, Says Focus on Poor Farmers "More Important Than Ever"

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today accepted World Food Program USA's George McGovern Leadership Award for his foundation's efforts to help small farmers in the developing …

OTE0011
24.10.2011 20:43

Innovative Aggregation Solution by Cardis International Addresses the Challenges of Durbin Amendment

The Durbin Amendment in the US is putting the card payments business model under significant pressure.

OTE0007
14.02.2011 14:03

ASSA-I Call for a More Stringent and Quality Based Approach to Cargo Security Globally

In light of the recent mail bombs discovered on board of cargo jets in the United Kingdom and Dubai, the Aviation Security Services Association International (ASSA-I) is calling for the quality of the …

OTE0010
03.11.2010 15:16

Biosign Signs European Distribution Agreement

Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the Biosign products in Switzerland, Germany, …

OTE0010
02.07.2010 14:51

Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis

- Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into …

OTE0008
30.04.2010 14:17

Stallergenes: Positive Results for Oralair(R) Phase III Trial in the USA

Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R).

OTE0003
19.04.2010 08:47

EANS-News: Epigenomics AG: PRESEPT Study Subject Enrollment Successfully Completed

Subtitle: 7,852 subjects prospectively enrolled including more than 50 cancer cases

OTE0004
17.12.2009 11:29

EANS-News: Strong Polysilicon Business Mitigates Sales and Earnings Drop in Q1 2009

- Q1 2009 Group sales drop 14 percent to €873 million - At €158 million, the operating result (EBITDA) was 46 percent lower than the prior-year figure - Positive net cash flow of €71 million - Full …

OTE0004
30.04.2009 07:15